LPCN
Lipocine Inc. · Healthcare · Market cap $13.2M
Insiders bought $82K net in the last 90 days ·0 sellers, 1 buyer· latest Form 4 filed Oct 2, 2026
Insider Buying
$517K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Latest filing
Oct 2, 2026
Higuchi John W.
Lipocine Inc. (LPCN) has 6 SEC Form 4 filings (7 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Oct 2, 2026.
Inside the rolling window, 2 insiders at Lipocine Inc. reported 7 open-market purchases totaling $517K and no open-market sales. The most active filer is Director Higuchi John W. with 5 filings. Insiders have net bought $466K over the trailing 6 months. The most recent open-market filing is a purchase of 9,037 shares by Director Higuchi John W., dated Sep 29, 2026, worth $19K.
- Industry:Biotechnology
- CEO:Mahesh V. Patel
- Employees:14
- HQ:Salt Lake City, UT, US
- IPO:2013-10-22
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Director | Purchase | 9,037 | $19K | Oct 2 | -22.0% | SEC ↗ | |
| Director | Purchase | 15,970 | $36K | Oct 2 | -22.0% | SEC ↗ | |
Higuchi John W.First in 6 months | Director | Purchase | 12,561 | $27K | Oct 1 | -22.7% | SEC ↗ |
| Director | Purchase | 40,000 | $81K | Apr 7 | -20.0% | SEC ↗ | |
| Chief Executive Officer | Purchase | 25,000 | $51K | Apr 6 | -17.5% | SEC ↗ | |
Higuchi John W.First filing | Director | Purchase | 123,000 | $252K | Apr 6 | -17.5% | SEC ↗ |
Patel Mahesh V.First filing | Chief Executive Officer | Purchase | 25,000 | $51K | Apr 2 | -22.0% | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does LPCN have?
Lipocine Inc. (LPCN) has 6 SEC Form 4 filings (7 transaction rows) in the rolling 365-day window, disclosed by 2 distinct insiders. Most recent filing: Oct 2, 2026.
When was the most recent SEC Form 4 filing for LPCN?
The most recent Form 4 filing for LPCN on Tracefour is dated Oct 2, 2026.
Who is the most active insider at LPCN?
The most active SEC Form 4 filer at LPCN in the rolling window is Director Higuchi John W., with 5 filings.
What is the net insider flow at LPCN over the last 6 months?
Over the trailing 180 days, insiders at LPCN have net bought $466K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at LPCN in the current window?
Inside the rolling window, insiders at LPCN bought $517K and sold $0 based on SEC Form 4 filings.
Can I get alerts for LPCN insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Lipocine Inc. (LPCN). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Lipocine Inc. is in the Healthcare sector.